ClassID:

94732

C07D273/01 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups  -  having one nitrogen atom

Recent Application in this class:
#1
20260144795
2026-05-28

SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS

#2
20260055069
2026-02-26

HETEROCYCLIC GLP-1 AGONISTS

#3
20250206708
2025-06-26

AN OXAZIRIDINE PLATFORM FOR TARGETING FUNCTIONAL ALLOSTERIC METHIONINE SITES

#4
20240376061
2024-11-14

HETEROCYCLIC GLP-1 AGONISTS

#5
20240368183
2024-11-07

Macrocyclic Compounds Having ENT1 Inhibiting Activity

#6
20240287008
2024-08-29

METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES

#7
20240132448
2024-04-25

ORGANIC COMPOUNDS AND USES THEREOF

#8
20230295139
2023-09-21

SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS

#9
20230203551
2023-06-29

Noscapinoid-producing Microbes and Methods of Making and Using the Same

#10
20230202992
2023-06-29

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SMALL-CELL LUNG CANCER ASSOCIATED WITH RON MUTANTS AND METHOD USING SAME

#11
20230192633
2023-06-22

Heterocyclic GLP-1 agonists

#12
20230148603
2023-05-18

DIOXAZOLINES AND THEIR USE AS HERBICIDES

#13
20230047296
2023-02-16

Nrf2 REGULATORS

#14
20230029852
2023-02-02

Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones

#15
20220204497
2022-06-30

NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME

#16
20220194930
2022-06-23

Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same

#17
20220002309
2022-01-06

SSAO INHIBITORS AND USES THEREOF

#18
20210323953
2021-10-21

1,3, 5-Dioxazine Derivatives, Method of Preparation and Application Thereof as Sulfide Scavenger

#19
20210249714
2021-08-12

Lithium Air Secondary Battery

#20
20210009551
2021-01-14

COMPOUNDS AND METHODS FOR TREATING FIBROSIS OR CANCER

#21
20200392091
2020-12-17

Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones

#22
20200331871
2020-10-22

Method for producing lactam compound, and lactam compound produced thereby

#23
20200283428
2020-09-10

Matrix metalloproteinase inhibitors and imaging agents, and methods using same

#24
20200262939
2020-08-20

Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit

#25
20200112058
2020-04-09

Electrolyte-additive for lithium-ion battery systems

#26
20200079759
2020-03-12

Nrf2 REGULATORS

#27
20190300515
2019-10-03

1,3,5-dioxazine derivatives, method of preparation and application thereof as sulfide scavenger

#28
20190276401
2019-09-12

Processes and intermediates for the preparation of Pimavanserin

#29
20190257838
2019-08-22

Redox-based reagents for methionine bioconjugation

#30
20180362543
2018-12-20

HIV REPLICATION INHIBITOR

#31
20180179187
2018-06-28

Nrf2 regulators

#32
20180148423
2018-05-31

Process for preparing (E)-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyl oxime

#33
20180037549
2018-02-08

Processes and intermediates for the preparation of Pimavanserin

#34
20170258756
2017-09-14

A Method for Topically Treating Actinic Keratosis on the Scalp with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)

#35
20170253898
2017-09-07

NOSCAPINOID-PRODUCING MICROBES AND METHODS OF MAKING AND USING THE SAME

#36
20170247357
2017-08-31

Pyridine derivatives as soft rock inhibitors

#37
20170158811
2017-06-08

Cyclic carbonate monomers and ring opened polycarbonates therefrom

#38
20160251324
2016-09-01

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#39
20160237047
2016-08-18

Process for preparing fluoxastrobin

#40
20160190467
2016-06-30

Amine-based compound and organic light-emitting device including the same

#41
20160150785
2016-06-02

Synergistic fungicidal active substance combinations

#42
20160137618
2016-05-19

Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals

#43
20160081343
2016-03-24

1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom

#44
20160046590
2016-02-18

SONIC HEDGEHOG MODULATORS

#45
20160024033
2016-01-28

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#46
20160009860
2016-01-14

Cyclic carbonate monomers and ring opened polycarbonates therefrom

#47
20150264932
2015-09-24

1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom

#48
20150258060
2015-09-17

Pharmaceutical composition for preventing or treating cancer

#49
20150246907
2015-09-03

PYRIDOMYCIN BASED COMPOUNDS EXHIBITING AN ANTITUBERCULAR ACTIVITY

#50
20150240006
2015-08-27

Solid-phase supports and uses thereof

#51
20140206760
2014-07-24

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#52
20140187531
2014-07-03

Apoptosis promoters

#53
20140094462
2014-04-03

SONIC HEDGEHOG MODULATORS

#54
20140081017
2014-03-20

Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents

#55
20140039011
2014-02-06

Macrocyclic urea and sulfamide derivatives as inhibitors of tafia

#56
20130267467
2013-10-10

Serine protease inhibitors

#57
20130196981
2013-08-01

Synergistic fungicidal active substance combinations

#58
20130196965
2013-08-01

Cyclic amides

#59
20130190488
2013-07-25

Apoptosis promoters

#60
20120029187
2012-02-02

HALOALKYLSULFONANILIDE DERIVATIVE

#61
20120015910
2012-01-19

Synergistic fungicidal active substance combinations

#62
20110257254
2011-10-20

Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor

#63
20110256129
2011-10-20

Apoptosis promoters

#64
20110178130
2011-07-21

Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

#65
20110144112
2011-06-16

Apoptosis promoters

#66
20110118330
2011-05-19

HIV protease inhibitors and methods for using

#67
20100113504
2010-05-06

AMIDE COMPOUNDS AND THEIR USE AS ANTITUMOR AGENTS

#68
20090318454
2009-12-24

NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT

#69
20080269302
2008-10-30

Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease

#70
20080188638
2008-08-07

Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof

#71
20080103135
2008-05-01

Phenylalkynes

#72
20080096876
2008-04-24

Phenylalkynes

#73
20070293530
2007-12-20

SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

#74
20070259444
2007-11-08

Chromoionophore and method of determining sodium ions

#75
20070072860
2007-03-29

Apoptosis promoters

#76
20070072837
2007-03-29

Phenylalkynes

#77
20070060579
2007-03-15

Synergistic fungicidal active substance combinations

#78
20070015787
2007-01-18

Apoptosis promoters

#79
20060258859
2006-11-16

Phenylalkynes

#80
18397710
2024-04-23

(2E)-4-[(4-chlorophenyl)amino]-N-phenyl-2-(phenylimino)-1,3,5-dioxazepine-7-carboxamide as an eco-friendly insecticidal agent against (boisd.)